HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Epithelial ovarian cancers (EOCs) often exhibit morphologic features of embryonic Müllerian duct-derived tissue lineages and colonize peritoneal surfaces that overlie connective and adipose tissues. However, the mechanisms that enable EOC cells to readily adapt to the peritoneal environment are poorly understood. In this study, we show that expression of HOXA9, a Müllerian-patterning gene, is strongly associated with poor outcomes in patients with EOC and in mouse xenograft models of EOC. Whereas HOXA9 promoted EOC growth in vivo, HOXA9 did not stimulate autonomous tumor cell growth in vitro. On the other hand, expression of HOXA9 in EOC cells induced normal peritoneal fibroblasts to express markers of cancer-associated fibroblasts (CAFs) and to stimulate growth of EOC and endothelial cells. Similarly, expression of HOXA9 in EOC cells induced normal adipose- and bone marrow-derived mesenchymal stem cells (MSCs) to acquire features of CAFs. These effects of HOXA9 were due in substantial part to its transcriptional activation of the gene encoding TGF-β2 that acted in a paracrine manner on peritoneal fibroblasts and MSCs to induce CXCL12, IL-6, and VEGF-A expression. These results indicate that HOXA9 expression in EOC cells promotes a microenvironment that is permissive for tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secretion of elevated levels of IL-6 by MSC has been detected upon interaction with malignant cells in several epithelial, hematopoietic and mesenchymal cancers (Table 2) [43, 69, 76, 77, 82, 115–119].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 2×
“Overexpression of Hoxa9 in primary bone marrow cells enhances hematopoietic stem cell regeneration, expands the myeloid progenitor pool, and collaborates with Meis1a to induce AML in mice (52, 53).”
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“Because TGF-β signaling induces EMT in many cell types (31), CAFs in +HOXA9 tumors might also derive from tumor cells.”
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664 · cited 2×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 11×
“A similar difference in FAP induction was also observed (Supplemental Figure 7B).”
InfluentialOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,485 · cited 1×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672 · cited 3×
“However, since progression of EOC is driven by multiple autocrine and paracrine mechanisms (1, 2), we cannot exclude the possibility that HOXA9 also promotes progression of this disease by stimulating other signaling pathways in tumor or host cells.”
Self-citationNovel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467 · cited 3×
“Tothill et al. classified tumors in the AOCS cohort into molecular subtypes by their gene expression signatures (19).”
InfluentialSanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Research works printed but not linked: 1
- Langley, 2003, Cancer Res., 63, 2971
Cited by
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
“In ovarian cancer through TGF-β signaling pathway, tumor-derived lysophosphatidic acid and exosomes promoted the differentiation of MSCs to CAFs, and cancer-derived TGF-β stimulated the expression of IL-6, C–X-C motif chemokine 12 (CXCL12), and VEGFA in CAFs to induce metastasis.(114) Accumulating evidence suggests th…”
BackgroundRegulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
Lee, W., Ko, S. Y., Mohamed, M. S., Kenny, H. A., Lengyel, E., & Naora, H. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181170 · Cited by 478
“ES2 cells that stably express tGFP have been previously described (Ko et al., 2012).”
BackgroundSelf-citationGuo, F., Wang, Y., Liu, J., Mok, S. C., Xue, F., & Zhang, W. (2016) · Oncogene · doi:10.1038/onc.2015.139 · Cited by 468
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Xia, A., Zhang, Y., Xu, J., Yin, T., & Lu, X.-J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 341
“These molecules include IL-10, type I IFNs, IDO, adenosine, VEGF-A, TGF-β, and IL-35.”
BackgroundInfluential
Metadata
- Authors
- Ko, S. Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., & Naora, H.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Wake Forest University (US)
- University of Chicago (US)
- Corresponding author
- Naora, Honami
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3603-3617
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461910
- OpenAlex
- W1988224215
- Cited by
- 132
- References
- 62
- Citations by year
- 2025: 10 · 2024: 9 · 2023: 11 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 14 · 2013: 14 · 2012: 2
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RP120390, 4r01ca111882-10)
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01-CA111882, CA141078, CA101826, R01CA101826, R01CA141078, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- HOXA9, epithelial ovarian cancer, cancer-associated fibroblasts, tumor microenvironment, Müllerian ducts, TGF-beta2, mesenchymal stem cells, adipose-derived stem cells, bone marrow-derived stem cells, CXCL12, interleukin-6, VEGF-A, paracrine signaling, tumor growth
- MeSH terms
- Adipose Tissue, Animals, Carcinoma, Cell Differentiation, Cell Division, Epithelial Cells, Female, Fibroblasts, Humans, Mice, Nude, Neoplasm Proteins, Ovarian Neoplasms, Peritoneal Neoplasms, Peritoneum, Prognosis, Tumor Cells, Cultured, Interleukin-6, Gene Expression Regulation, Neoplastic, Culture Media, Conditioned, Homeodomain Proteins, Paracrine Communication, Vascular Endothelial Growth Factor A, Endothelial Cells, Mice, Kaplan-Meier Estimate, Transforming Growth Factor beta2, Chemokine CXCL12, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. https://app.cochat.ai/papers/10.1172/jci62229
- The paper
- Ko, S. Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., & Naora, H. (2012). HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. Journal of Clinical Investigation. https://doi.org/10.1172/jci62229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.